Obi O, Polite P, Fish K, DeLuca R, Feustel P, Mandis A
    
    
    Lung. 2025; 203(1):31.
  
  
    PMID: 39841245
    
          PMC: 11754370.
    
          DOI: 10.1007/s00408-024-00761-8.
      
 
                                  
  
    Day J, Hamann P
    
    
    Diagnostics (Basel). 2025; 14(24.
  
  
    PMID: 39767202
    
          PMC: 11675675.
    
          DOI: 10.3390/diagnostics14242842.
      
 
                                  
  
    Bardakci M, Ayhan Albayrak G
    
    
    Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(4):e2024049.
  
  
    PMID: 39655588
    
          PMC: 11708957.
    
          DOI: 10.36141/svdld.v41i4.15760.
      
 
                                  
  
    Moller J, Prior T, Hilberg O, Birring S, Bendstrup E
    
    
    ERJ Open Res. 2024; 10(6).
  
  
    PMID: 39534770
    
          PMC: 11551859.
    
          DOI: 10.1183/23120541.00160-2024.
      
 
                                  
  
    Sterniste G, Hackner K, Moazedi-Furst F, Grasl M, Idzko M, Shao G
    
    
    Wien Klin Wochenschr. 2024; 136(Suppl 17):669-687.
  
  
    PMID: 39382646
    
          PMC: 11464578.
    
          DOI: 10.1007/s00508-024-02444-z.
      
 
                              
              
                              
                                      
  Diagnostic delay of sarcoidosis: an integrated systematic review.
  
    Namsrai T, Phillips C, Parkinson A, Gregory D, Kelly E, Cook M
    
    
    Orphanet J Rare Dis. 2024; 19(1):156.
  
  
    PMID: 38605384
    
          PMC: 11010435.
    
          DOI: 10.1186/s13023-024-03152-7.
      
 
                                          
                                                          
  Health-related quality of life in cardiac sarcoidosis: a systematic review.
  
    Quijano-Campos J, Sekhri N, Thillai M, Sanders J
    
    
    Eur Heart J Open. 2023; 3(2):oead009.
  
  
    PMID: 36974155
    
          PMC: 10039618.
    
          DOI: 10.1093/ehjopen/oead009.
      
 
                                          
                                                          
  Identifying a core outcome set for pulmonary sarcoidosis research - the Foundation for Sarcoidosis Research - Sarcoidosis Clinical OUtcomes Taskforce (SCOUT).
  
    Harman N, Gorst S, Williamson P, Barnathan E, Baughman R, Judson M
    
    
    Sarcoidosis Vasc Diffuse Lung Dis. 2023; 39(3):e2022030.
  
  
    PMID: 36791046
    
          PMC: 9766848.
    
          DOI: 10.36141/svdld.v39i3.12319.
      
 
                                          
                                                          
  Efzofitimod for the Treatment of Pulmonary Sarcoidosis.
  
    Culver D, Aryal S, Barney J, Hsia C, James W, Maier L
    
    
    Chest. 2022; 163(4):881-890.
  
  
    PMID: 36356657
    
          PMC: 10258437.
    
          DOI: 10.1016/j.chest.2022.10.037.
      
 
                                          
                                                          
  Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study.
  
    Strykowski R, Patel D, Neto M, Hena K, Gulati M, Maier L
    
    
    BMJ Open Respir Res. 2022; 9(1).
  
  
    PMID: 35882424
    
          PMC: 9329732.
    
          DOI: 10.1136/bmjresp-2022-001254.
      
 
                                          
                                                          
  Scout - sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis.
  
    Harman N, Gorst S, Williamson P, Barnathan E, Baughman R, Judson M
    
    
    Sarcoidosis Vasc Diffuse Lung Dis. 2021; 38(3):e2021034.
  
  
    PMID: 34744426
    
          PMC: 8552570.
    
          DOI: 10.36141/svdld.v38i3.10737.
      
 
                                          
                                                          
  Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis.
  
    Bernardinello N, Petrarulo S, Balestro E, Cocconcelli E, Veltkamp M, Spagnolo P
    
    
    Diagnostics (Basel). 2021; 11(9).
  
  
    PMID: 34573900
    
          PMC: 8472810.
    
          DOI: 10.3390/diagnostics11091558.
      
 
                                          
                                                          
  How to Tackle the Diagnosis and Treatment in the Diverse Scenarios of Extrapulmonary Sarcoidosis.
  
    Valeyre D, Jeny F, Rotenberg C, Bouvry D, Uzunhan Y, Seve P
    
    
    Adv Ther. 2021; 38(9):4605-4627.
  
  
    PMID: 34296400
    
          PMC: 8408061.
    
          DOI: 10.1007/s12325-021-01832-5.
      
 
                                          
                                                          
  Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes.
  
    Saketkoo L, Russell A, Jensen K, Mandizha J, Tavee J, Newton J
    
    
    Diagnostics (Basel). 2021; 11(6).
  
  
    PMID: 34203584
    
          PMC: 8232334.
    
          DOI: 10.3390/diagnostics11061089.
      
 
                                          
                                                          
  Predictors of cough-specific and generic quality of life in sarcoidosis patients.
  
    Gvozdenovic B, Mihailovic-Vucinic V, Vukovic M, Stjepanovic M, Buha I, Mihailovic S
    
    
    Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):158-168.
  
  
    PMID: 33093779
    
          PMC: 7569550.
    
          DOI: 10.36141/svdld.v37i2.9234.
      
 
                                          
                                                          
  Management of Sarcoidosis, a Selection of Topical Items Updating.
  
    Valeyre D, Bernaudin J
    
    
    J Clin Med. 2020; 9(10).
  
  
    PMID: 33036457
    
          PMC: 7599542.
    
          DOI: 10.3390/jcm9103220.
      
 
                                          
                                                          
  Comprehensive Care for Patients with Sarcoidosis.
  
    Moor C, Kahlmann V, Culver D, Wijsenbeek M
    
    
    J Clin Med. 2020; 9(2).
  
  
    PMID: 32024123
    
          PMC: 7074229.
    
          DOI: 10.3390/jcm9020390.
      
 
                                          
                                                          
  Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.
  
    Judson M
    
    
    F1000Res. 2020; 8.
  
  
    PMID: 31942239
    
          PMC: 6944258.
    
          DOI: 10.12688/f1000research.20696.1.
      
 
                                          
                                                          
  Quality of Life of Couples Living with Sarcoidosis.
  
    Voortman M, Hendriks C, Lodder P, Drent M, de Vries J
    
    
    Respiration. 2019; 98(5):373-382.
  
  
    PMID: 31437834
    
          PMC: 6888889.
    
          DOI: 10.1159/000501657.
      
 
                                          
                                                          
  Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability.
  
    Hendriks C, Saketkoo L, Elfferich M, de Vries J, Wijnen P, Drent M
    
    
    Lung. 2019; 197(4):407-413.
  
  
    PMID: 31101981
    
          PMC: 6647075.
    
          DOI: 10.1007/s00408-019-00234-3.